Pillstats
Rx only · Solution, Concentrate · Oral

Dexamethasone Intensol

Dexamethasone

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA01AC02
RxCUI (US)3264
US makers1 labelers
Packages1
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.215$0.430$0.644$0.859Nov 2025Apr 2026Jul 2026
$0.747
Latest avg · Jul 22, 2026
+1%
Since Nov 19, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.0K6.0K9.0K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.0K
Rx · 2026 Q1
205K
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.